You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 1176 to 1200 of about 5901
Next 25
12/24/2018
Identification of a novel role of IL-13Ra2 in human Glioblastoma multiforme: interleukin-13 mediates signal transduction through AP-1 pathway
12/21/2018
FDA TO FACILITATE ACCESS TO UNAPPROVED DRUGS
12/20/2018
Penn Medicine Launching Telemedicine Platform for Brain Tumor Consults
12/19/2018
Dopamine Receptor D5 is a Modulator of Tumor Response to Dopamine Receptor D2 Antagonism.
12/15/2018
An early feasibility study of the Nativis Voyager® device in patients with recurrent glioblastoma: first cohort in US.
Finding Hope in the Face of Brain Cancer
12/13/2018
Tumor treating fields increases membrane permeability in glioblastoma cells.
12/10/2018
Survivin Vaccine for Newly Diagnosed GBM
Musella Foundation awards 2 more pediatric brain tumor research grants!
12/05/2018
Cancer therapy shows promise for some brain tumors
12/03/2018
Help Us Better Understand Glioblastoma Multiforme - Paid survey!
Functional Biological Activity of Sorafenib as a Tumor-Treating Field Sensitizer for Glioblastoma Therapy.
11/22/2018
FDA Grants Fast Track Designation to ONC201 for the Treatment of Adult Recurrent H3 K27M-mutant High-Grade Glioma
SNO 2018: Trials of Two Oncolytic Viruses for Recurrent Malignant Glioma Are Progressing
The impact of traveling distance and hospital volume on post-surgical outcomes for patients with glioblastoma.
Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target
Giving Tuesday! Donate to Musella Foundation
11/20/2018
SNO Highlights
Musella Foundation 2018 Highlights
11/11/2018
Mebendazole and radiation in combination increase survival through anticancer mechanisms in an intracranial rodent model of malignant meningioma.
11/10/2018
The role of erlotinib and the Optune device in a patient with an epidermal growth factor receptor viii amplified glioblastoma.
11/08/2018
Late toxicity in long-term survivors from a phase 2 study of concurrent radiation therapy, temozolomide and valproic acid for newly diagnosed glioblastoma.
Hebrew U Researchers Discover Promising Treatment Against Aggressive Brain Tumors
11/07/2018
ONC201 Investigator Meeting and Clinical Efficacy in H3 K27M-mutant Glioma to be Presented at Society for Neuro-Oncology Conference
11/02/2018
Prospective feasibility and safety assessment of surgical biopsy for patients with newly diagnosed diffuse intrinsic pontine glioma